-
Health outcomes during follow-up for children younger than 5 years of age wit...
Health outcomes during follow-up for children younger than 5 years of age with prevalence ratios adjusted for age in months and gender. -
r37980778c78--c15b4f1d86589f2d614f58528d595fb9
BackgroundOver 34 countries in Africa have introduced rotavirus vaccine to their national immunization programs: monovalent (Rotarix®, RV1) and pentavalent (RotaTeq®, RV5) after... -
r37980778c78--d59fc54b1e55b8d3bc53a0fc829d774a
Prevalence1 of diarrhea in children age 12–59 months by socioeconomic, demographic and residence related variables in selected countries. -
Results of multivariable binary logistic regression examining the effect of m...
Results of multivariable binary logistic regression examining the effect of measles vaccination on ARI in children age 12–59 months in selected countries. -
Criteria used for scoring clinical signs and symptoms, including fecal consis...
Criteria used for scoring clinical signs and symptoms, including fecal consistency, overall health, hydration, and appetite. -
Prevalence<sup>1</sup> of ARI in children age 12–59 months by socioeconomic, ...
Prevalence1 of ARI in children age 12–59 months by socioeconomic, demographic and residence related variables in selected countries. -
r37980778c78--39c329f5ff344287f2a56822bc722f21
Diarrhea severity dependent response ratesa against IgA and IgG of CFA/I antigen. -
Comparison of clinical characteristics between patients with positives vs neg...
Comparison of clinical characteristics between patients with positives vs negative results and mono vs polimicrobial infections. -
r37980778c78--8c3e5b41d3efba664513e4186d5b502a
Severity dependent response ratesa against IgA and IgG of LTB antigen. -
r37980778c78--7d777f073c32d49b7e9f80b005882955
A reliable and effective human challenge model is needed to help down-select the most promising ETEC vaccines currently under development. Such a model would need to reliably... -
r37980778c78--f07418f50c13faf763b337ed434964e3
Response ratesa against IgA and IgG of LTB antigen by dose. -
Clinical outcomes of the subjects challenged with ETEC H10407.
Clinical outcomes of the subjects challenged with ETEC H10407. -
Primary and secondary outcomes.
aIncludes acute renal failure, acute respiratory distress syndrome, heart failure, cerebral impairment (seizures, unconsciousness, motor/cognitive loss) among women who... -
Study characteristics of 17 studies included for systematic review and meta-a...
Study characteristics of 17 studies included for systematic review and meta-analysis by year, country, vaccine, objective, seasonal peak, age group, study type, number of cases... -
r37980778c78--3ac5d770f2fd6a4873e48ed2c7bc1ed6
Annual and seasonal trends for suspected cases of six diseases from Afghanistan’s Disease Early Warning System, 2009–2015. -
S1 Supporting Information -
Spreadsheet named "Gain & Phase" contains means and standard errors from the statistical analyses involving visual transitions. Spreadsheet named "Phase Variability" contains... -
Clinical characteristics according to immune status.
Clinical characteristics according to immune status. -
r37980778c78--536eb6f4b160c02a165336f48fec327c
Characteristics of suspected cases of six diseases from Afghanistan’s Disease Early Warning System, 2009–2015.
